Transpek Industry Ltd

Rating Details

• Long-term/Short-term fund-based/Non-fund-based - Others: [ICRA]A+(Stable)/[ICRA]A1; Reaffirmed; Rs 99.75 crore.
• Short-term - Non-fund-based - Others: [ICRA]A1; Reaffirmed; Rs 40.56 crore.
• Fixed Deposits: [ICRA]A+ (Stable); Reaffirmed; Rs 30.00 crore.
• Total rated: Rs 140.31 crore.
• Surveillance due within one year from rating communication letter.
• Fixed deposits rating valid for the life of the programme until withdrawn.

Transpek Industry Ltd - Closure of Trading Window

AGM Details

• 60th AGM held 15 September 2026 at 3:00 PM via Instameet VC/OAVM.
• Deemed venue: Vadodara address.
• Remote e-voting window: 12–14 September 2026.
• Cut-off date for voting: 7 September 2026.
• Notice and annual report issued 18 August 2026.

Key Resolutions

• Resolution 1: Adopt standalone and consolidated financial statements; passed with requisite majority.
• Resolution 2: Declare dividend on equity shares for FY ending 31 March 2026; passed.
• Resolution 3: Appoint director in place of Shri Ashwin C. Shroff; passed.
• Resolution 4: Ratify remuneration of Cost Auditors for FY ending 31 March 2027; passed.

Voting Results

• No invalid votes recorded; all resolutions passed.

AGM filing chunk contains no extractable governance or financial updates

Rating Details

• CRISIL assigned ratings to Transpek Industry’s bank facilities and unsecured fixed deposits.
• CRISIL rating letters referenced for bank facilities and unsecured FDs are attached.

Financial Performance

• Q1 FY27 revenue: INR 155.1 crores; down 6.5% YoY.
• EBITDA: INR 24.1 crores; EBITDA margin 15.6%.
• PAT: INR 8.9 crores.
• Polymer revenue share: 48.7%; Specialty chemicals 22.5%; Pharma 10.11%; Others 18.7%.
• International revenue share: 84.4%; North America >52% of regional mix.
• Polymer contribution declined from 60-65% historically to ~45-50% now.

Strategy & Portfolio

• Diversifying into non-acid, non-alkyl chloride chemistries; expanding polymer offerings.
• Two high-end polymers developed in R&D; progressing to kilo/pilot scale with TÜV tests.
• Polymers used in medical implants, automotive, aerospace, electronics, semiconductor, oil & gas.
• Developing polymer modifiers/additives; three products; one near pilot stage.

R&D & Pilot Infrastructure

• R&D headcount to double this financial year; multi-purpose pilot plant planned (four streams).
• Pilot plant design completed; construction to start; ready in about 6-7 months.

Capex & Projects

• Capex guidance: INR 250 crores over 5-6 years; multi-phase execution.
• Odisha site: board approval targeted in 25-30 days; feasibility study; decision by November-end if approved.
• Permissions: EC in a pre-approved chemical zone; single-window process; 3-4 months for approvals; commercial production 1.5–2 years after permissions.
• Payback for Odisha capex: 4 to 5 years.

Outlook & Guidance

• FY27 revenue growth guidance: 15% to 20% over last year.
• Long-term objective: double company size in 5–6 years.

Q&A Highlights

• Arclin/DuPont renewal risk discussed; management pursuing diversification; if renewal is not available, volume shift plans exist.
• DuPont/Arclin pricing: rupee depreciation is passed through to customers under cost-plus models.
• Competition: high-end aramid applications (e.g., aerospace, firefighting) face less direct competition; Chinese/Korean capacity growth focused on lower-end markets.
• Current capacity utilization constrained by product-specific streams and permissions; Odisha expansion seen as essential to growth.

Meeting Details

• No analyst/investor meeting details provided in this filing chunk.

Business overview

• Chlorination chemistry and acid chlorides; diversified polymers and specialty chemicals.
• Expanding non-acid, non-alkyl chloride chemistries; Odisha land site under consideration.

Key operational highlights

• Q1 FY27 revenue from operations ₹151.1 crore.
• Q1 FY27 EBITDA ₹24.1 crore; PAT ₹8.9 crore.
• EBITDA margin 15.6%; PAT margin 5.8%.
• FY26 revenue ₹621.2 crore; EBITDA ₹117.9 crore; PAT ₹45.6 crore.
• New site options; Odisha land approval; Eurasia and South America customers.
• EcoVadis Gold award and Responsible Care certification.
• Capacity: multipurpose plants totaling 66,000 MTPA.
• R&D: DSIR-approved facility; plan to double R&D team.
• Geographic expansion to Eurasia and South America.

Financial performance

• Total revenue from operations (Q1 FY27) ₹155.1 crore.
• EBITDA (including Other Income) ₹24.1 crore.
• EBITDA margin 15.6% in Q1 FY27.
• PAT ₹8.9 crore; PAT margin 5.8%.
• FY26 revenue ₹645.7 crore; EBITDA ₹117.9 crore; PAT ₹45.6 crore.
• March-26: Total equity ₹767.4 crore; Total assets ₹1,008.3 crore.
• Net cash from operating activities ₹78.5 crore.
• Cash and cash equivalents ₹57.8 crore.
• Borrowings ₹42.5 crore (current ₹28.1 cr; non-current ₹14.4 cr).
• FY26 EBITDA margin 18.3%; EBIT margin 10.7%.

Capital structure & liquidity

• Debt position: total borrowings ₹42.5 crore; liquidity: cash ₹57.8 crore.
• Positive operating cash flow: ₹78.5 crore in Mar-26.

Strategic priorities & outlook

• Develop additional acid chlorides while advancing other products to commercialization in 2026-27.
• Geographic expansion; strengthening Eurasia and South America presence.
• R&D expansion; doubling team and infrastructure; sustainability initiatives.

Risks & mitigation

• Raw material price escalation (sulphur, chlorine) and higher freight costs.
• Transit time constraints and vessel availability; macro uncertainty from West Asia.
• Mitigation: innovation, geographic diversification, and portfolio expansion.

Governance & leadership

• Board chaired by Ashwin C. Shroff; MD is Bimal Mehta.
• Independent directors include Rita Teaotia and others.
• R&D facility recognized by Government of India.

Financial performance

• Revenue from operations: 62,119.90; down from 64,985.31 FY24-25
• PAT: 4,564.81; down 6.35% YoY
• EPS: ₹81.73 (basic and diluted)
• Export share: 83.10% of revenue
• Dividend per share: ₹20

Operations & capacity

• Installed capacity: 66,000 MTPA at Ekalbara
• Exports accounted for 83.1% of revenue in FY26
• Global presence across 16 countries; exports dominating revenue
• Three new non-acid chloride products under development
• Phased AI roadmap to enhance process control and efficiency

Capital structure & liquidity

• Borrowings: 4,245.54 Lakhs; Lease liabilities: 3,196.92 Lakhs
• Net debt: 7,442.46 Lakhs; Debt/Equity: 0.10
• Cash & cash equivalents: 5,783.11 Lakhs
• Capex: energy conservation ₹75 Lakhs; renewable energy investments
• No material liquidity concerns reported

ESG & sustainability

• EcoVadis Gold Medal; UN Global Compact; RSPO; Great Place to Work
• Scope 1/2/3 emissions: 192; 11,127; 89,557 tCO2e
• Water: 181,372 KL withdrawal; water intensity 0.0029 per turnover
• Waste: 2115.25 MT generated; 1174.10 MT recycled; 801.63 MT disposed
• FE11PL renewable energy 2.8 MW; commercialisation expected May 2026

Governance & risk

• Avtar Singh resigned 31 Mar 2026; MD transition underway
• Ashwin C. Shroff to be reappointed; Board to consider at AGM
• TNT & Associates appointed as Secretarial Auditor; no qualifications
• CSR Committee active; Risk Management Committee in place
• AGM details and governance disclosures updated

Dividends & AGM

• Dividend ₹20 per equity share; AGM 15 Sep 2026 via VC/OAVM
• DTAA options for non-residents; TDS guidelines clarified
• Notice and Annual Report sent electronically; no proxies allowed
• Tax compliance and share transfer arrangements explained in AGM notice
• Dividend tax payment and IEPF-related matters communicated

Outlook & risks

• 2025-26 faced volatility in crude prices and geopolitics; Western demand subdued
• FY2026-27 focus: product commercialization, geographic expansion, margin discipline
• AI and digitalisation to protect margins as scale increases
• Sustainability initiatives to maintain EcoVadis Gold status
• Management emphasizes disciplined cost control and resilient supply chains

Meeting Details

• Date/time: 20 August 2026, 4:00 PM IST
• Event: Business Update Call
• Type: group investor call; Mode: virtual

Participants

• Key participant: Managing Director

Purpose

• Discuss operational and financial performance

Additional Notes

• RSVP via Strategic Growth Advisors Pvt. Ltd.